Follistim and Clomid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Follistim (follitropin alfa/beta) and Clomid (clomiphene citrate). Common drug interactions include abortion threatened among females.
The phase IV clinical study analyzes what interactions people have when they take Follistim and Clomid. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Follistim?
Follistim has active ingredients of follitropin alfa/beta. It is often used in infertility. eHealthMe is studying from 1,802 Follistim users. Check the latest studies of Follistim.
What is Clomid?
Clomid has active ingredients of clomiphene citrate. It is often used in infertility female. eHealthMe is studying from 1,350 Clomid users. Check the latest studies of Clomid.
12 people who take Follistim and Clomid together, and have interactions are studied.
What are the common drug interactions of Follistim and Clomid, by gender? *:
female:
- Abortion threatened (abortion with vaginal bleeding)
- Threatened labour (premature labour is the onset of labour between 24 and 37 weeks of pregnancy)
- Drug exposure before pregnancy
- Drug exposure during pregnancy
- Dyspepsia (indigestion)
- Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
- Haemorrhagic ovarian cyst (bleeding ovarian cyst)
- Inflammation
- Injection site reaction
- Necrosis (the death of body tissue)
male:
n/a
What are the common drug interactions of Follistim and Clomid, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Adhesion
- Cytogenetic abnormality
- Drug exposure before pregnancy
- Drug exposure during pregnancy
- Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
- Haemorrhagic ovarian cyst (bleeding ovarian cyst)
- Inflammation
- Necrosis (the death of body tissue)
- Ovarian hyperstimulation syndrome (excess egg stimulation from ovary due to medicine)
- Ovarian necrosis (death of ovary)
40-49:
- Burning sensation
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Dyspepsia (indigestion)
- Pain
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Ovulation Induction: 2 people, 16.67%
- Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Follistim and Clomid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Follistim and Clomid:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Follistim:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clomid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Follistim and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clomid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on follitropin alfa/beta and clomiphene citrate (the active ingredients of Follistim and Clomid, respectively), and Follistim and Clomid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tylenol cause Mean Cell Haemoglobin Decreased? - a second ago
- Drug interactions of Pantoprazole and Tigecycline - a second ago
- Could Ditropan cause Appetite Decreased? - 2 seconds ago
- Could Pantoprazole Sodium cause Systemic Lupus Erythematosus? - 2 seconds ago
- Could Ditropan cause Appetite - Decreased? - 2 seconds ago
- Could Lioresal cause Adjustment Disorder? - 3 seconds ago
- Drug interactions of Amlodipine Besylate and Atarax - 6 seconds ago
- Sinusitis and Infusion Site Haemorrhage - 6 seconds ago
- Acute Myeloid Leukaemia and Appetite Decreased - 8 seconds ago
- Gastrointestinal Stromal Tumor and Appetite Decreased - 9 seconds ago